CTL access to tissue antigen is restricted in vivo

Area of Science:

• Immunology
• Hepatology
• Transplantation Immunology

Background:

• Hepatitis B virus (HBV) infection is a major global health concern.
• CD8+ cytotoxic T lymphocytes (CTLs) play a critical role in viral clearance and immunopathology.
• Understanding CTL interactions with infected tissues is crucial for developing effective therapies.

Purpose of the Study:

• To investigate the tissue-specific effects of hepatitis B surface antigen (HBsAg)-specific CTLs in a transgenic mouse model.
• To elucidate the role of vascular anatomy in mediating CTL access to HBsAg-expressing tissues.
• To understand the mechanisms underlying liver-specific immune responses.

Main Methods:

• Generation of HBsAg-specific, MHC class I-restricted CD8+ CTL lines and clones.
• Intravenous and extravascular injection of CTLs into transgenic mice expressing HBsAg.
• Histopathological analysis of liver, kidney, and brain tissues.
• Microvascular anatomical studies of different tissues.

Main Results:

• Intravenous injection of HBsAg-specific CTLs induced severe necroinflammatory liver disease.
• CTLs failed to cause disease in other HBsAg-expressing tissues despite widespread antigen expression.
• Extravascular injection demonstrated CTL cytopathicity for renal tubules and choroid plexus epithelial cells.
• Hepatic sinusoids have discontinuous endothelium and lack a basement membrane, unlike other tissues.

Conclusions:

• The unique microvascular structure of the liver facilitates CTL access to HBsAg.
• Vascular endothelium and basement membranes in other tissues act as barriers to CTL infiltration.
• These barriers must be breached by other events for CTLs to access endogenously synthesized antigens in non-hepatic tissues.